Pathway cross-talk network strategy reveals key pathways in non-small cell lung cancer.

CONCLUSION: We successfully revealed the disease pathway cross-talks and explored 5 key pathways in NSCLC, which may be the underlying therapeutic targets for lung cancer.
PMID: 29135110 [PubMed - in process]

Source: Journal of B.U.ON. - November 15, 2017 Category: Cancer & Oncology Tags: J BUON Source Type: research